Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| smooth muscle cell | 34 studies | 47% ± 21% | |
| pericyte | 24 studies | 35% ± 16% | |
| fibroblast | 18 studies | 35% ± 18% | |
| myofibroblast cell | 12 studies | 37% ± 19% | |
| glutamatergic neuron | 10 studies | 42% ± 24% | |
| endothelial cell | 7 studies | 30% ± 8% | |
| cardiac muscle cell | 6 studies | 63% ± 24% | |
| astrocyte | 6 studies | 40% ± 16% | |
| neuron | 5 studies | 24% ± 7% | |
| connective tissue cell | 5 studies | 26% ± 9% | |
| muscle cell | 4 studies | 58% ± 24% | |
| GABAergic neuron | 3 studies | 47% ± 13% | |
| interneuron | 3 studies | 51% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 85% | 54631.97 | 208 / 245 | 98% | 64.38 | 494 / 502 |
| esophagus | 83% | 110775.46 | 1198 / 1445 | 61% | 18.32 | 111 / 183 |
| breast | 67% | 13449.67 | 309 / 459 | 74% | 9.59 | 825 / 1118 |
| uterus | 96% | 43983.93 | 163 / 170 | 36% | 13.89 | 164 / 459 |
| bladder | 86% | 100976.48 | 18 / 21 | 41% | 9.60 | 208 / 504 |
| intestine | 78% | 92842.29 | 752 / 966 | 48% | 8.26 | 253 / 527 |
| stomach | 56% | 48361.26 | 202 / 359 | 59% | 30.44 | 169 / 286 |
| muscle | 100% | 190659.56 | 801 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 97% | 73826.02 | 1297 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 70% | 18235.79 | 842 / 1204 | 0% | 0 | 0 / 0 |
| ovary | 44% | 8793.88 | 80 / 180 | 22% | 1.97 | 93 / 430 |
| brain | 0% | 29.50 | 4 / 2642 | 65% | 5.32 | 460 / 705 |
| pancreas | 0% | 0 | 0 / 328 | 65% | 12.93 | 116 / 178 |
| kidney | 4% | 722.73 | 4 / 89 | 59% | 9.01 | 532 / 901 |
| adrenal gland | 1% | 147.93 | 2 / 258 | 61% | 5.44 | 141 / 230 |
| thymus | 8% | 1683.73 | 52 / 653 | 53% | 3.45 | 318 / 605 |
| tonsil | 0% | 0 | 0 / 0 | 60% | 15.06 | 27 / 45 |
| lung | 11% | 1953.87 | 66 / 578 | 38% | 15.19 | 438 / 1155 |
| skin | 10% | 1990.62 | 182 / 1809 | 23% | 3.08 | 108 / 472 |
| heart | 32% | 7348.89 | 277 / 861 | 0% | 0 | 0 / 0 |
| liver | 0% | 56.88 | 1 / 226 | 12% | 0.69 | 49 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.31 | 2 / 29 |
| spleen | 1% | 119.86 | 2 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 20.68 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0032233 | Biological process | positive regulation of actin filament bundle assembly |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0001725 | Cellular component | stress fiber |
| GO_0015629 | Cellular component | actin cytoskeleton |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005925 | Cellular component | focal adhesion |
| GO_0030018 | Cellular component | Z disc |
| GO_0005634 | Cellular component | nucleus |
| GO_0051393 | Molecular function | alpha-actinin binding |
| GO_0051371 | Molecular function | muscle alpha-actinin binding |
| GO_0071889 | Molecular function | 14-3-3 protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003779 | Molecular function | actin binding |
| GO_0031005 | Molecular function | filamin binding |
| Gene name | SYNPO2 |
| Protein name | Synaptopodin 2 (cDNA FLJ52650, moderately similar to Synaptopodin-2) Synaptopodin-2 (Genethonin-2) (Myopodin) Synaptopodin 2 |
| Synonyms | |
| Description | FUNCTION: Has an actin-binding and actin-bundling activity. Can induce the formation of F-actin networks in an isoform-specific manner . At the sarcomeric Z lines is proposed to act as adapter protein that links nascent myofibers to the sarcolemma via ZYX and may play a role in early assembly and stabilization of the Z lines. Involved in autophagosome formation. May play a role in chaperone-assisted selective autophagy (CASA) involved in Z lines maintenance in striated muscle under mechanical tension; may link the client-processing CASA chaperone machinery to a membrane-tethering and fusion complex providing autophagosome membranes (By similarity). Involved in regulation of cell migration . May be a tumor suppressor . .; FUNCTION: [Isoform 1]: Involved in regulation of cell migration. Can induce formation of thick, irregular actin bundles in the cell body. .; FUNCTION: [Isoform 2]: Involved in regulation of cell migration. Can induce long, well-organized actin bundles frequently orientated in parallel along the long axis of the cell showing characteristics of contractile ventral stress fibers. .; FUNCTION: [Isoform 3]: Involved in regulation of cell migration. Can induce an amorphous actin meshwork throughout the cell body containing a mixture of long and short, randomly organized thick and thin actin bundles. .; FUNCTION: [Isoform 4]: Can induce long, well-organized actin bundles frequently orientated in parallel along the long axis of the cell showing characteristics of contractile ventral stress fibers. .; FUNCTION: [Isoform 5]: Involved in regulation of cell migration in part dependent on the Rho-ROCK cascade; can promote formation of nascent focal adhesions, actin bundles at the leading cell edge and lamellipodia . Can induce formation of thick, irregular actin bundles in the cell body; the induced actin network is associated with enhanced cell migration in vitro. . |
| Accessions | ENST00000627783.2 [Q9UMS6-5] ENST00000434046.6 [Q9UMS6-3] ENST00000610556.4 [Q9UMS6-4] B9EG60 B4E258 ENST00000504178.1 ENST00000448416.6 ENST00000307142.9 [Q9UMS6-2] ENST00000429713.7 [Q9UMS6-1] H0Y9Y3 Q9UMS6 |